Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B
- 13 December 2001
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 66 (2) , 171-178
- https://doi.org/10.1002/jmv.2127
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis BHepatology, 2000
- Core Promoter Mutations and Genotypes in Relation to Viral Replication and Liver Damage in East Asian Hepatitis B Virus CarriersThe Journal of Infectious Diseases, 1999
- Genotypes, nt 1858 Variants, and Geographic Origin of Hepatitis B Virus—Large‐Scale Analysis Using a New Genotyping MethodThe Journal of Infectious Diseases, 1997
- Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis BJournal of Hepatology, 1996
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detectionJournal of General Virology, 1995
- Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis BGastroenterology, 1995
- Natural History and Control of Perinatally Acquired Hepatitis B Virus InfectionDigestive Diseases, 1992
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive FactorsHepatology, 1989